We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The expanded application makes this the first available ...
FDA Approves Expanded Use of Eculizumab (Soliris) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children Provided by GlobeNewswire Mar 10, 2025 1:09pm ...
Eculizumab is now approved for pediatric patients with gMG, expanding treatment options for this population. The monoclonal antibody targets the complement system, preventing tissue damage in gMG ...
(RTTNews) - AstraZeneca reported that Soliris has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis in paediatric patients who are anti-acetylcholine ...
Teva and Samsung Bioepis are offering Epysqli, which is is a biosimilar to Alexion Pharmaceuticals' Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic ...
Soliris (eculizumab) is a prescription drug used to treat certain rare autoimmune conditions. It comes as a liquid solution for intravenous infusion by a healthcare professional. The dosage depends on ...
Soliris (eculizumab) is a prescription drug used to treat certain rare autoimmune conditions. Soliris can cause side effects that range from mild to serious. Examples include headache and back pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback